0
Skip to Content
Alliance for a Stronger FDA
About Us
Leadership
Join Us
List of Members
Who can Become a Member
Budget Docs
Contact
Alliance Archives
Join Us
Alliance for a Stronger FDA
About Us
Leadership
Join Us
List of Members
Who can Become a Member
Budget Docs
Contact
Alliance Archives
Join Us
Folder: About
Back
About Us
Leadership
Folder: Members
Back
Join Us
List of Members
Who can Become a Member
Budget Docs
Contact
Alliance Archives
Join Us
Advocacy at a Glance Guest User 10/25/19 Advocacy at a Glance Guest User 10/25/19

Final Senate Action on “Domestic” Minibus (Including Ag/FDA) Set for Next Week

Read More
Advocacy at a Glance Guest User 10/19/19 Advocacy at a Glance Guest User 10/19/19

Congress Returns; Appears No Closer to Reconciling House and Senate 302(b) Allocations or Solving Border Wall Funding

Read More
Advocacy at a Glance Guest User 10/5/19 Advocacy at a Glance Guest User 10/5/19

FY 20 Starts Peacefully; No Shutdown, But Restrictions Under a CR

Read More
Advocacy at a Glance Guest User 9/30/19 Advocacy at a Glance Guest User 9/30/19

President to Sign CR; Government Will Stay Open to November 21

Read More
Advocacy at a Glance Guest User 9/20/19 Advocacy at a Glance Guest User 9/20/19

Senate Unveils Proposed $80 Million Increase for FDA

Read More
Advocacy at a Glance Guest User 9/13/19 Advocacy at a Glance Guest User 9/13/19

Senate Appropriations to Mark-Up Ag/FDA Bill on Tuesday, September 17

Read More
Advocacy at a Glance Guest User 9/6/19 Advocacy at a Glance Guest User 9/6/19

Congress Returns September 9/10 to Hectic Fall, Including Funding Bills

Read More
Advocacy at a Glance Guest User 8/23/19 Advocacy at a Glance Guest User 8/23/19

Appropriations Bills Face Unknown Fate in September

Read More
Advocacy at a Glance Guest User 8/11/19 Advocacy at a Glance Guest User 8/11/19

BBA Becomes Law; Difficult Path to Appropriation Bills by October 1

Read More
Advocacy at a Glance Guest User 8/2/19 Advocacy at a Glance Guest User 8/2/19

Budget Deal Passes Senate, President Agrees to Sign

Read More
Advocacy at a Glance Guest User 7/26/19 Advocacy at a Glance Guest User 7/26/19

Budget Deal at Last: Resolves Top-Line Numbers for FY 20 and 21

Read More
Advocacy at a Glance Guest User 7/19/19 Advocacy at a Glance Guest User 7/19/19

Put the Bubbly Back in the Fridge: No Budget Deal Quite Yet

Read More
Advocacy at a Glance Guest User 7/12/19 Advocacy at a Glance Guest User 7/12/19

House and Senate Action (or Lack) on FY 20 Appropriations

Read More
Advocacy at a Glance Guest User 6/29/19 Advocacy at a Glance Guest User 6/29/19

House Passes H.R. 3055, Including Ag/FDA Appropriations

Read More
Advocacy at a Glance Guest User 6/24/19 Advocacy at a Glance Guest User 6/24/19

Confused By the Budget and Appropriations Process?

Read More
Advocacy at a Glance Guest User 5/31/19 Advocacy at a Glance Guest User 5/31/19

House Appropriations To Move Quickly in June; Full-Committee Ag/FDA Mark-up on June 4

Read More
Advocacy at a Glance Guest User 5/23/19 Advocacy at a Glance Guest User 5/23/19

House Subcommittee Proposes $184 million (6%) Increase for FDA’s FY 20 BA (Taxpayer) Funding

Read More
Advocacy at a Glance Guest User 5/17/19 Advocacy at a Glance Guest User 5/17/19

Mixed Signals on Whether the White House Wants a Budget Deal

Read More
Advocacy at a Glance Guest User 5/10/19 Advocacy at a Glance Guest User 5/10/19

No Budget Agreement: House Moves Forward, Senate Waits

Read More
Advocacy at a Glance Guest User 5/3/19 Advocacy at a Glance Guest User 5/3/19

House Appropriations Subcommittees Begin FY 20 Bill Approvals

Read More
Newer Posts
Older Posts

The Alliance for a Stronger FDA | 918 14th Street, SE, Apt 1 Washington, DC 20003 | cartier@strengthenfda.org | LinkedIn

The Alliance for a Stronger FDA is an independent, not-for-profit 501(c)(4) corporation registered in the state of Maryland. It is not affiliated with the FDA and current FDA employees can not become members of the Alliance. For information from the FDA, please click here. Copyright 2025, Alliance for a Stronger FDA.